The moss Physcomitrella patens has been used as an experimental organism for more than 80 years. Within the last 15 years, its use as a model to explore plant functions has increased enormously. The ability to use gene targeting and RNA interference methods to study gene function, the availability of many tools for comparative and functional genomics (including a sequenced and assembled genome, physical and genetic maps, and >250,000 expressed sequence tags), and a dominant haploid phase that allows direct forward genetic analysis have all led to a surge of new activity. P. patens can be easily cultured and spends the majority of its life cycle in the haploid state, allowing the application of experimental techniques similar to those used in microbes and yeast. Its development is relatively simple, and it generates only a few tissues that contain a limited number of cell types. Although mosses lack vascular tissue, true roots/stems/leaves, and flowers and seeds, many signaling pathways found in angiosperms are intact in moss. For example, the phytohormones auxin, cytokinin, and abscisic acid, as well as the photomorphogenic pigments phytochrome and cryptochrome, are all interwoven into distinct but overlapping pathways and linked to clear developmental phenotypes. In addition, about one quarter of the moss genome contains genes with no known function based on sequence motifs, raising the likelihood of successful discovery efforts to identify new and novel gene functions. The methods outlined in this chapter will enhance the use of the P. patens model system in many laboratories throughout the world.
BACKGROUND INFORMATION
The moss P. patens (Hedw.) Bruch & Schimp was first established as a laboratory experimental system in the 1920s by Fritz von Wettstein (1924) , who studied the effects of ploidy variation and inheritance patterns in interspecific and intergeneric crosses within the moss family Funariaceae. The modern era of Physcomitrella research dates to the work of Paulinus Engel (1968) , who generated the first biochemical and morphological mutants in the species.
Like all land plants, the moss life cycle consists of a multicellular haploid gametophyte generation that alternates with a morphologically distinct diploid sporophyte generation. But unlike vascular plants, the gametophyte (Fig. 1C) is the dominant portion of the moss life cycle. Haploid spores germinate to produce a filamentous protonemal stage (Fig. 1D) . Protonemata are initially composed of chloronemal cells that are full of large chloroplasts. Chloronemal cells extend by serial division of the apical cell, and subapical cells branch to form new apices. Some apical chloronemal cells develop into a second cell type, caulonemata. Caulonemal filaments contain fewer and less-well-developed chloroplasts. But they extend more rapidly than chloronema; the division times of the apical cells of caulonema and chloronema are about 6 and 24 hours, respectively. The subapical cells of caulonemal filaments branch to form more filaments and leafy stems, called gametophores (Fig. 1E) , on which gametes are produced. Moss is monoecious: Both male and female gametes are produced on the same gametophore. Although self-fertilization is common, cross-fertilization can occur when two strains are grown adjacent to each other. Fertilized zygotes develop into sporophytes that remain attached to the gametophore. Within the sporophyte, spore mother cells give rise to spores meiotically.
P. patens is small, and in nature, the gametophores seldom reach more than 5 mm in height. It is mostly found on wet soil and, in particular, on sites that are exposed to seasonal flooding, such as the banks of lakes, ponds, rivers, and drainage ditches (Crum and Anderson 1981) . Although it is distributed widely in the northern hemisphere, it is uncommon throughout its range. Natural populations produce spores from September to March, depending on the locality. Although P. patens itself is restricted to North America and Europe, other morphologically similar species are found in Africa, Asia, South America, and Australia. Many variants of P. patens have been given species or subspecies rank, although the degree to which the morphological features that distinguish these taxa have a genetic basis has not been established experimentally. Natural hybrids between closely related species in the family Funariaceae, similar to those produced in culture by von Wettstein, have been documented in several localities (Pettet 1964) .
SOURCES AND HUSBANDRY
The strain of P. patens used by Engel was generated from a single spore that was obtained in 1962 from a plant in Gransden Wood, Huntingdonshire, England by Dr. H.W.K. Whitehouse. This strain has since been used by many laboratories, but it is routinely taken through its sexual cycle about every year, during which time cultures are reestablished from individual spores. Therefore, Gransden strains will often be identified by the laboratory and the year in which a spore was used to start a new culture (e.g., the material used to sequence the P. patens genome came from the Gransden St. Louis 2004 strain). Because of gametophytic haploidy, all such strains differ only as a result of mutation or epigenetic variation. More recently, additional collections of P. patens have been made from Europe and North America, and these are now being genetically and morphologically characterized . This new collection is curated and distributed from the University of Freiburg, Germany (see http://www.cosmoss.org).
P. patens can be grown on either solid (agar-based) or liquid media (for details, see Protocol 1). Temperatures between 24°C and 26°C are used for routine culture, although little difference in growth rate is observed from 20°C to 26°C. Growth is slower but still satisfactory at 15°C, and this has been used as the permissive temperature when temperature-sensitive mutants are sought. For routine culture, continuous light from fluorescent tubes at an intensity of between 5 and 20 Wm -2 is generally satisfactory, although the exact quality of light is not critical. Many laboratories use intermittent light, most commonly a 16-hour light/8-hour dark cycle. This regime entrains the cell cycle of chloronemata. Development is slower under intermittent light regimes; developmental landmarks are achieved in response to the total hours of illumination experienced.
RELATED SPECIES
Two additional moss species are currently used for experimental research: Ceratodon purpureus and Tortula ruralis. C. purpureus is one of the most common mosses in exposed rock and soil in temperate regions of the northern and southern hemispheres. In the spring, it is easily recognized by the purple seta that elevates the diploid sporophyte. This species also has a long history in experimental biology; the term "heterochromatin" was coined for the dark-staining sex chromosomes of this and other moss species (Heitz 1928) . A genetic map of C. purpureus has been constructed, and several natural isolates have been extensively characterized (for review, see McDaniel et al. 2008) . Cultures of C. purpureus, isolated by E. Hartmann in Germany and by D.J. Cove in Austria, are used by several labs worldwide, principally to study phototropism and gravitropism. C. purpureus is so abundant that the isolation of additional cultures is fairly straightforward; isolates currently in use are available from D.J. Cove (Washington University, St. Louis). All of the experimental procedures that are described for P. patens are also used for C. purpureus with few modifications.
T. ruralis has been used principally to study water stress because it is able to withstand complete desiccation, similar to seeds. Although a modest collection of expressed sequence tags (ESTs) is available for T. ruralis (Oliver et al. 2004) , it is less amenable to growth in culture than either C. purpureus or P. patens and has not been shown to be easily transformable or to undergo efficient gene targeting.
USES OF THE P. PATENS MODEL SYSTEM
The common ancestor of mosses, such as P. patens, and seed plants, such as Arabidopsis thaliana, pines, and other species, lived approximately 480 million years ago (Mya). Comparative studies including members of both of these lineages allow us to infer biological properties of this common ancestor, giving us a richer understanding of the diversity of plant life. This may have practical value to the extent that understanding diverse plant systems yields novel solutions to problems in crop breeding, for example.
During the last several years, P. patens has been used as a model to study various components of cell, developmental, and evolutionary plant biology. Its development is relatively simple, and it generates only a few tissues that contain a limited number of cell types. Although mosses lack vascular tissue, true roots/stems/leaves, and flowers and seeds, many signaling pathways found in angiosperms are intact in moss. For example, the phytohormones auxin, cytokinin, and abscisic acid, as well as the photomorphogenic pigments phytochrome and cryptochrome, are all interwoven into distinct but overlapping pathways and linked to clear developmental phenotypes Rensing et al. 2008) .
RNA interference (RNAi) methods (Bezanilla et al. 2005) have been used to analyze the role of ARPC1 (Harries et al. 2005) , a member of the Arp2/3 complex, and profilin (Vidali et al. 2007 ) in tip growth. Khandelwal et al. (2007) studied the role of the P. patens presenilin protein using RNAi. Presenilin possesses γ-secretase activity, is involved in Alzheimer's disease (AD), and is an intermediate in the NOTCH signaling pathway of animal cells; however, unlike animal cells, P. patens and other plants do not contain this pathway although the protein is present. The observed mutant phenotype indicates a possible role for presenilin that is independent of γ-secretase activity and the NOTCH pathway, thus raising the possibility of using P. patens as a novel system for studying the off-target effects of AD therapy and drug discovery.
Targeted gene deletion and replacement methods have been used to study the role of another member of the Arp2/3 complex, ARPC4 , and BRICK1, a member of the Scar/Wave family (Perroud and Quatrano 2008) . Like the other papers referenced above, the excellent cell biology of P. patens was used to localize ARPC4 and BRICK1 in growing tip filaments. Transcriptome (Nishiyama et al. 2003; Cuming et al. 2007 ) and metabolic studies (Thelander et al. 2005; Kaewsuwan et al. 2006; Schulte et al. 2006) , as well as detailed analyses of microRNAs (Axtell et al. 2006 (Axtell et al. , 2007 , have now appeared using P. patens. Finally, comparative genomic studies have elucidated the role of the transcriptional regulators LEAFY (Maizel et al. 2005) , ABI3 , and transcription factors involved in rooting function (Menand et al. 2007) 
GENETICS, GENOMICS, AND ASSOCIATED RESOURCES
P. patens is amenable to classical genetics studies, with the haploidy of the gametophyte allowing straightforward analysis (Cove 2005) . Efforts to identify polymorphisms among isolates of P. patens are proceeding and will enable map-based cloning of both ethylmethanesulfonate (EMS)-and UVgenerated mutants (for a method to generate such mutants, see Protocol 4) , as well as quantitative trait locus (QTL) mapping of natural variants . A number of mutant strains are available from different laboratories (http://www.cosmoss.org; http://biology4.wustl. edu/moss), including those having requirements for the vitamins p-aminobenzoic acid, nicotinic acid, and thiamine. Vitamin requirements have been exploited to increase the frequency of crossfertilization. When two complementary p-aminobenzoic acid or nicotinic acid auxotrophs are grown together on a medium with only a limited level of supplementation, the sporophytes produced are the result of cross-fertilization (Courtice and Cove 1978) .
No universally accepted system of gene nomenclature has been adopted, but there has been general agreement that annotated genes will be identified by numbers. Trivial names can then be added as synonyms. Originally, the system used for trivial names was similar to that used for many bacteria and fungi: Each symbol was composed of a three-letter lowercase code to designate the mutant gene family, an uppercase letter to designate the family member, and a number to designate the allele (e.g., pabA4). More recently, some laboratories have adopted the system used by the yeast and A. thaliana communities, designating the family member by a number rather than by an uppercase letter (e.g., pab1-4). But no general agreement has yet been reached as to which system should be adopted.
The assembled P. patens genome (~487 Mb), representing eight times coverage, has been released by the Joint Genome Institute (http://shake.jgi-psf.org/Phypa1/Phypa1.home.html; Rensing et al. 2008) . In parallel, sequences of full-length cDNAs, additional ESTs, and bacterial artificial chromosome (BAC) ends are being developed, and updates can be accessed through the Physcomitrella Genome Consortium website (http://www.mossgenome.org). Various libraries and vectors are available (see links at http://biology4.wustl.edu/moss/links.html), as is an Agilent microarray (MO gene), which contains 44,000 features (~28,000 gene models) based on all of the open reading frames (ORFs) in the draft genome (Fig. 2) .
Several tools are available for the functional analysis of genes in P. patens. For example, the dexamethasone-(Chakhparonian 2001), heat-shock- (Saidi et al. 2005) , and homoserine-lactone- (You et al. 2006) inducible promoter systems have all been successfully used in this system. Forward genetics can be used to dissect gene function using a shuttle-mutagenesis library (Nishiyama et al. 2000; Hayashida et al. 2005) . A targeted deletion library that was created using ESTs (Schween et al. 2005 ) has also been used for functional analysis (Schulte et al. 2006) . Transformation can be performed via polyethylene glycol (PEG)-mediated DNA uptake by isolated protoplasts (see Protocol 5), via Agrobacterium (see Protocol 6), or via a gene gun (see Protocol 7), and somatic hybridization has been used to analyze mutants genetically (see Protocol 3) . Reverse genetics using gene targeting is a tool of choice for manipulating individual genes in P. patens, and RNAi allows the down-regulation of gene families. An RNAi system has been developed in P. patens that silences the nucleus-localized green fluorescent protein::β-glucuronidase (GFP::GUS) fusion protein at the same time that it silences the gene(s) of interest (Bezanilla et al. 2005) .
TECHNICAL APPROACHES
The following eight protocols outline techniques for manipulating P. patens in the laboratory and include three transformation methods (Protocols 5-7). P. patens (and C. purpureus) have a high frequency of gene targeting (Kamisugi et al. 2005 (Kamisugi et al. , 2006 ; when a transforming construct contains a genomic sequence, the construct is targeted to the corresponding sequence in the genome. This can be exploited to knock out or modify a gene.
For knockout, aim to replace the coding sequence with a selection cassette and to border this on each side by about 1000 bp of genomic sequence. Linear DNA fragments generated by polymerase chain reaction (PCR) give the highest rates of targeting. It is convenient to perform a number of transformations at the same time (ten is not difficult). For each experiment, make sure to include a minus DNA control to assess protoplast viability. Figure 1G shows a plate of transformants that have been growing for 2 weeks on selective media. Following transformation, the regenerants are of three types:
• Transient: These do not retain resistance upon subculture.
• Unstable: These exhibit slow growth on selective medium. Resistance is probably not transmitted through meiosis and is rapidly lost when selection is relaxed.
• Stable: These grow on selective medium almost as fast as on nonselective medium. Resistance is transmitted regularly through meiosis and is retained even when selection is absent. AU: Fig 1G citation 
Culturing the Moss Physcomitrella patens
Here, we present a series of methods for culturing the moss P. patens at all stages of its life cycle. Gametophytes are axenically cultured on solid agar-based media (Methods IA and IB, adapted from Grimsley et al. 1979) and in shaken liquid cultures (Method IC). Growth rates in shaken liquid cultures are not as great as those obtained on solid media or in bioreactors (Boyd et al. 1988) , especially if these are supplied with CO 2 . AU: See query. For long-term storage of gametophytes, cultures are maintained on solid medium at 10°C in a very short day (see Method IIA; Fig. 1H,I ), but cryopreservation (Method IIB, adapted from Grimsley and Withers 1983) may also be used. Finally, sporophytes are generated by self-fertilization and sexual crossing (Method III, adapted from Ashton and Cove 1977) .
MATERIALS
The recipes for items marked with <R> are on page XX. • For somatic tissue, place a clump of gametophyte tissue (usually 1-2 mm in diameter) on the agar. The size of the clump is not critical. However, for growth tests, the clumps should be as uniform as possible, and uniformity is best achieved by picking the tissue while looking through a microscope.
Seal the Petri dishes with Micropore surgical tape.

This reduces the risk of contamination without affecting the growth or development of the cultures. Do not seal cultures with Parafilm; this slows growth and prevents regeneration.
3. Incubate the cultures in an incubator at 25°C with constant white light at intensities between 5 and 20 Wm -2 .
Depending on the purpose of the procedure, growth under these conditions may range from a few days (e.g., to score antibiotic resistance) to several weeks (e.g., to score the requirements of some vitamins). For an image of 6-day-old protonemata grown under these conditions, see Figure 1A .
B. Using Petri Dishes Containing Solid Medium Overlaid with Cellophane
1. Overlay a Petri dish containing appropriately supplemented solid BCD medium with a sterilized cellophane disc. Allow the dish to stand for at least 10 minutes to allow the cellophane to hydrate and then, if necessary, straighten the disc while maintaining sterility. 2. Obtain one dish of protonemal tissue from plants that have developed for about 10 days from tissue-clump inocula growing on appropriately supplemented BCD medium (see Method IA). Harvest the tissue with a spatula as shown in Figure 1B .
3. Add the tissue to 10 ml of H 2 O, and blend it for about 2 minutes. 6. Harvest the tissue by scraping it from the cellophane using a sterile spatula.
Once tissue is growing on cellophane, it is convenient to use this tissue (instead of the tissue described in
Step 2) for further inocula by repeating Steps 3-6. However, do not repeat this cycle more than three times.
C. Using Liquid Medium
1. Add tissue from one cellophane-overlay plate (see Method IB) to 10 ml of H 2 O and blend as described in Step 3 of Method IB.
2. Inoculate 200 ml of appropriately supplemented liquid BCD medium (in a 1-liter Erlenmeyer flask) with 2 ml of the tissue suspension from Step 1.
Other quantities of the liquid BCD medium and/or the tissue suspension may be used instead.
Shake the cultures on a platform shaker.
Vigorous agitation is not necessary for growth.
II. Long-term Storage of Gametophyte Tissue
A. Storage on Solid Medium
1. Place a clump of gametophyte tissue (usually 1-2 mm in diameter) in each plastic tube containing agar medium (usually, appropriately supplemented solid BCD medium).
2. Make sure that the lids are not tightly sealed. For screw-cap lids, tighten the cap and then release it about one quarter of a turn. ) for long-term storage. ).
3. To each of ten 2-ml sterile plastic vials, add 2 ml of DMSO-glucose solution. Then add one tenth of the tissue on the plate to each vial. Incubate the vials for 1 hour at 20°C.
4.
Freeze the vials at a rate of 1°C per minute to -35°C using a controlled low-temperature ethanol bath.
5. Place the vials in liquid nitrogen for storage.
It is advisable to freeze multiple aliquots of tissue. Recovery from cryopreservation is usually good for vigorous strains, but some mutant strains recover poorly. To thaw the cultures, proceed with
Steps 6-8.
6. Retrieve the vials from the liquid nitrogen and place them in a water bath at 30°C until thawed.
7. After thawing, add tissue from one vial to 10 ml of H 2 O. Allow the mixture to stand for 30 minutes at room temperature.
Inoculate the tissue suspension from
Step 7 onto appropriate solid medium as described in Method IA (use 1-2 ml of the tissue suspension per plate).
III. Production of Sporophytes and Isolation of Spores
1. Prepare test tubes (25 x 150 mm) with between 15 and 20 ml of solid nitrogen-free medium containing 400 µM of KNO 3 .
Alternatively, fill Magenta jars two-thirds full with the same medium.
2. Inoculate the medium with protonemata by placing a clump of tissue (usually 1-2 mm in diameter) on the agar.
• If sporophytes resulting from self-fertilization are required, place a single inoculum into a test tube. Alternatively, place four inocula into a Magenta jar.
• To establish a sexual cross, place one or more inocula of each strain into a tube (or a Magenta jar).
• Harvest and test the sporophytes produced from sexual crosses individually because they may result from either self-or cross-fertilization. Strains that have been kept for prolonged periods in vegetative culture may loose fertility.
3. Place the cap on the tube, but do not completely tighten it. 10. Use fine forceps to harvest pale brown sporophytes by separating them from the gametophytic material. Do not take the green or yellow sporophytes (these are immature) or the darkbrown sporophytes (these burst easily).
11. Pinch the base of the seta, which can be identified by a zone of pigmentation, to release the spore capsule. 12. Place one or more sporophyte capsules in a sterile 1.5-ml microcentrifuge tube. Sterilize the capsules by adding 1 ml of 70% ethanol and incubating for 4 minutes at room temperature.
13. Remove the ethanol. Gently rinse the sporophyte capsules three times with 1 ml of H 2 O at room temperature.
14. Add 1 ml of H 2 O and transfer the tube to 4°C.
This step increases spore germination, but some spores will germinate if it is omitted.
15. Crush the sporophyte capsules and mix to produce a spore suspension. This protocol describes how to isolate individual protoplasts from young gametophyte tissue (Method I) and how to regenerate them into plants (Method II) if desired. It is adapted from a protocol described by Grimsley et al. (1977) .
MATERIALS
The recipes for items marked with <R> are on page XX. 3. To isolate protoplasts from the digested tissue, sterilely filter the tissue-driselase mixture through mesh with a pore size of 100 µm.
Reagents
Sterilely refilter the filtrate from
Step 3 through mesh with a pore size of 50 µm.
5. Sediment the protoplasts by centrifuging the filtrate from Step 4 at 100-200g for 4 minutes at room temperature with no braking.
6. Discard the supernatant.
7.
Resuspend the protoplast pellet in PW. Use about the same volume as the volume of driselase used in Step 1.
Repeat Steps 5-7.
This should yield about 10 6 protoplasts per 90-mm-diameter plate of tissue cultured for 7 days as described in Method IB. Protoplasts can be used in a number of techniques (e.g., Protocols 3, 5, and 6) . If protoplasts are to be plated without further manipulation, proceed to Method II.
II. Protoplast Regeneration
1. Estimate the density of protoplasts using a hemocytometer. Adjust the volume of the protoplast suspension with XXXX so that the density of protoplasts is approximately XXXXX.
2.
Determine the quantity of molten PRMT needed (use 1 volume of protoplast suspension for every 2 volumes of molten PRMT). Gently add the protoplast suspension from Step 1 to the appropriate volume of molten PRMT.
3. Pipette 1 ml of the protoplast-PRMT mixture gently but quickly onto a 90-mm PRMB plate overlaid with cellophane.
Alternatively, use 400 µl of the protoplast-PRMT mixture to cover a 50-mm dish.
4.
Incubate the plate for 3 or 4 days at 25°C with strong, constant light (intensities >5 Wm -2 ).
For images of 3-day-old filaments regenerating from protoplasts, see Figure 1F .
5. After about 4 days, transfer the protoplasts to appropriately supplemented, fresh BCD medium as described in Method XX of Protocol 1. 
Protocol 3
Somatic Hybridization in P. patens Using PEG-induced Protoplast Fusion
As an alternative to sexual crossing (see Protocol 1), protoplasts from two strains of moss (P. patens) can be hybridized using polyethylene glycol (PEG). This protocol for PEG-induced protoplast fusion was adapted from the protocol described by Grimsley et al. (1977) . Although the efficiency is low, it requires no sophisticated apparatus. Hybrids are readily obtained using complementary auxotrophic mutants or strains with transgenic antibiotic resistance markers. It is now routine to obtain hybrids using transgenic strains that are hygromycin-or G418-resistant by selecting hybrids on medium containing both antibiotics.
MATERIALS
The recipes for items marked with <R> are on page XX.
Reagents
BCD medium (solid) <R>, containing common moss media supplements <R> and antibiotics <R> as necessary PEG solution for protoplast fusion (PEG/F) <R> 
Protoplast regeneration medium for the top layer (PRMT) <R>
This medium should be melted and kept at 45°C in a water bath.
Protoplast wash (PW) solution <R>
For each hybridization, prepare 30 ml of PW solution.
Protoplasts from two different P. patens strains
These protoplasts are isolated as described in Protocol 2, Method I.
Equipment
Centrifuge Hemocytometer (optional; see Step 2) Incubator with temperature control and white light at intensities between 5 and 20 Wm -2 (e.g., Percival Scientific Model CU-36L5) Petri dishes (90 mm), sterile METHOD 1. For each strain to be hybridized, resuspend 10 6 protoplasts (approximately the number produced on one 90-mm plate in Protocol 2, Method I) in 2.5 ml of PW.
2. Combine 2.5 ml of each of the two strains to be hybridized.
Judge the density of protoplasts by eye (if preferred, density can be determined using a hemocytometer). If the yield of protoplasts from one strain is poor, the yield of hybrids involving that strain can be maximized by mixing with an excess of the other strain.
3. Sediment the mixed protoplasts by centrifugation at 100-200g for 4 minutes at room temperature with no braking.
4. Discard the supernatant. Resuspend the protoplasts in 250 µl of PW.
5.
Hybridize the two strains of protoplasts by performing the following steps on schedule:
i. At 0 minutes, add 750 µl of PEG/F and mix gently.
ii. At 40 minutes, add 1.5 ml of PW and mix gently.
iii. At 50 minutes, add 10 ml of PW and mix gently.
iv. At 60 minutes, add 10 ml of PW and mix gently.
v. At 70 minutes, sediment the protoplasts by centrifugation at 100-200g for 4 minutes at room temperature with no braking. Discard the supernatant and resuspend the pellet in 1 ml of PW.
Multiple hybridizations can be performed in parallel. It should be possible to do these at 30-second intervals.
6. Add the protoplast suspension to 7 ml of molten PRMT and plate 2 ml onto each of four plates of PRMB overlaid with cellophane. In addition, to estimate the survival of the individual component strains, add 50 µl of the protoplast suspension to 8 ml of molten PRMT and plate 2 ml onto each of four plates of PRMB overlaid with cellophane. Incubate all plates at 25°C with strong, constant light (intensities >5 Wm -2 ).
7. After 5-6 days (when protoplasts have regenerated, but growth is still not great), transfer the protoplasts from Step 6 to Petri dishes containing the appropriate BCD selective medium to select for hybrids. In addition, to estimate the survival of the individual component strains, transfer the cellophane overlays from Step 6 onto the appropriate BCD media to select for one or the other component strain. Incubate all plates under the conditions described in Step 6.
Selection of hybrids using vitamin auxotrophies usually takes about 3 weeks; using transgenic antibiotic resistances, hybrids can usually be identified after only 7 days.
AU: Steps 6 and 7. Incubation conditions OK?
Protocol 4
Chemical and UV Mutagenesis of Spores and Protonemal Tissue
This protocol describes how to mutagenize spores and protonemal tissue from moss (P. patens) using chemicals or UV light. Spores are mutagenized using the alkylating agents N-methyl-N′-nitro-Nnitrosoguanidine (NTG) and ethylmethanesulfonate (EMS) (Methods IA and IB, respectively), and protonemal tissue is mutagenized with NTG and UV light (Methods IIA and IIB, respectively). The chemical mutagenesis protocols were adapted from those described by Ashton and Cove (1977) and Boyd et al. (1988) . Compared to alkylating agents, UV is less effective as a mutagen, but it may be advantageous because it is less hazardous and may not lead to clustered lesions.
MATERIALS
CAUTION: See Appendix XX for appropriate handling of materials marked with <!>. 
Reagents
BCD medium (solid) <R>, containing common moss media supplements <R> as necessary Ethylmethanesulfonate (EMS) <!> N-methyl-N′-nitro-N-nitrosoguanidine (NTG) <!>
METHODS
Perform all chemical mutagenesis procedures in safe handling facilities for mutagens.
I. Mutagenesis of Spores
A. Using NTG 1. Prepare 10 ml of a spore suspension containing about 10 6 spores in sterile Tris-maleate buffer. 3. Mix the spore suspension with the NTG solution and shake it gently for an additional 30 minutes at 25°C.
4.
Terminate the treatment by sedimenting the spores by centrifugation (XXXg for XX minutes at room temperature) and dispose of the supernatant safely.
Usually about 10% of the originally viable spores survive this treatment.
5. Wash the spores three times as follows:
i. Add 10 ml of H 2 O to the tube.
ii. Centrifuge the tube at XXXg for XX minutes at room temperature.
iii. Discard the supernatant.
6. After the final wash, resuspend the spores in XXX. Spread about 100 surviving spores onto the surface of appropriately supplemented BCD medium in 90-mm Petri dishes.
7. Incubate the plate under the desired conditions. For standard cultivating procedures and conditions, see Protocol 1.
The mutagenic treatment results in an initial delay in development, but once germinated, the sporelings grow as usual.
B. Using EMS
1. Prepare 9.5 ml of a spore suspension containing about 10 6 spores in sterile 100 mM orthophosphoric acid (pH 7.0).
2.
Observing strict safety procedures, add 500 µl of EMS.
3.
Incubate the mixture for 45 minutes at 25°C.
4.
Terminate the treatment by adding 10 ml of sterile 400 mM sodium thiosulfate.
5. Sediment the spores by centrifugation (XXXg for XX minutes at room temperature) and dispose of the supernatant safely.
Usually 35-40% of the originally viable spores survive this treatment.
6. Wash the spores three times as follows:
7.
After the final wash, resuspend the spores in XXX. Spread about 100 surviving spores onto the surface of appropriately supplemented BCD medium in 90-mm Petri dishes.
8. Incubate the plate under the desired conditions. For standard cultivating procedures and conditions, see Protocol 1.
The mutagenic treatment results in an initial delay in development, but once germinated, the sporelings grow as usual.
II. Mutagenesis of Protonemal Tissue
A. Using NTG 
Transformation Using Direct DNA Uptake by Protoplasts
This protocol describes how to transform moss (P. patens) protoplasts using PEG-mediated DNA uptake. The transformation rates for direct uptake by protoplasts of DNA with and without genomic sequence (a targeting construct) are typically 10 -5 and 10 -3
, respectively (these are the frequencies of stable transformants among regenerants surviving the transformation procedure).
MATERIALS
The recipes for items marked with <R> are on page XX. 
Protoplast regeneration medium for the bottom layer (PRMB) <R>
For each transformation, prepare four plates containing PRMB and overlay with sterile cellophane. 1. Resuspend the protoplasts in 8.5% (w/v) D-mannitol solution. Use 2.5 ml for each plate of tissue digested.
Protoplast regeneration medium for the top layer (PRMT) <R>
2. Use a hemocytometer to estimate protoplast density.
3. Centrifuge Speed (in g), for how long, and at what temp? and discard the supernatant.
Resuspend the protoplasts in MMM solution at a concentration of 1.6 x 10 6 protoplasts/ml.
4.
Prepare the DNA to be used in transformation by dispensing 15-30 µg of DNA into a sterile 10-ml tube. Centrifuge briefly to bring the DNA to the bottom of the tube.
5. Add 300 µl of protoplast suspension from Step 3 and 300 µl of PEG/T solution to the DNA from Step 4. Gently invert the tube to mix.
6. Heat the mixture in a water bath for 5 minutes at 45°C.
7.
Transfer the tube to room temperature (20°C) and leave it for 5 minutes.
8. Add 300 µl of 8.5% D-mannitol solution. Gently invert the tube to mix. Wait at least 1 minute.
Repeat
Step 8 four times.
10. Add 1 ml of 8.5% D-mannitol solution. Invert gently to mix. Wait at least 1 minute.
Step 10 four times.
12. Centrifuge at 100-200g for 5 minutes at room temperature.
13. Discard the supernatant and resuspend the pellet in 500 µl of 8.5% D-mannitol solution.
14. Add 2.5 ml of molten PRMT. Dispense 1 ml of the mixture to each of three 90-mm plates containing PRMB and overlaid with cellophane.
15. Incubate the plates in continuous white light for 5 days at 25°C. 
Transformation Using T-DNA Mutagenesis
In this protocol, the transformation of moss (P. patens) protoplasts is performed via Agrobacteriummediated transfer of T-DNA. The transformation rate for this protocol is typically 10 -4 (expressed as the frequency of stable transformants among regenerants surviving the transformation procedure).
MATERIALS
CAUTION: See Appendix XX for appropriate handling of materials marked with <!>.
Reagents
Acetoseringone (3′5′-dimethoxy-4′-hydroxyacetophenone) (100 mM) <!>, prepared in ethanol <!> Agrobacterium tumefaciens culture (strain Agl-1) Micropore surgical tape (3M, 1530-0) Petri dishes (SIZE?) (sterile) Spectrophotometer METHOD 1. Use a hemocytometer to estimate the density of protoplasts.
2.
Centrifuge the protoplasts at 100-200g for 4 minutes at room temperature with no braking and discard the supernatant. Resuspend the protoplasts in PRML at a concentration of 5 x 10 5 protoplasts/ml.
3.
For each milliliter of protoplast suspension, prepare a Petri dish containing 9 ml of PRML.
4. Add 1 ml of protoplast suspension to each prepared Petri dish.
5.
Calculate the quantity of Agrobacterium culture to add by determining the OD 600 with a spectrophotometer. Add 110 µl of culture per 1.0 OD 600 to each Petri dish.
6. Add 20 µl of 100 mM acetoseringone to each Petri dish.
7. Wrap each dish with Micropore surgical tape and incubate for 48 hours at 25°C under a 16-hour light/8-hour dark cycle.
The protoplasts will tend to adhere to the Petri dish surface during incubation.
8. Use a pipette to carefully resuspend the protoplasts.
9.
Centrifuge the protoplasts at 100-200g for 4 minutes at room temperature with no braking and discard the supernatant. Resuspend the pellet in 10 ml of APW.
Repeat
Step 9 twice, but after the last centrifugation step, resuspend the pellet in 2 ml of APW and add 2.4 ml of modified PRMT.
11. Dispense 1.1 ml of the protoplast suspension into each of four Petri dishes containing modified PRMB and overlaid with sterile cellophane discs. Incubate the dishes for 7 days at 25°C under continuous white light.
12.
Transfer the cellophane overlays onto plates containing selection medium and incubate for 7 days at 25°C under a 16-hour light/8-hour dark cycle.
13. Transfer the cellophane overlays to plates containing modified BCD medium and incubate for 7 days at 25°C under continuous white light. AU: incubation conditions OK in Steps 13, 15?
14. Transfer the cellophane overlays to plates containing selection medium and incubate for 7-10 days at 25°C under a 16-hour light/8-hour dark cycle.
15. Pick small clumps of tissue from each vigorously growing plant and place them on plates containing modified BCD medium. Incubate the plates for 7 days at 25°C under continuous white light. 4. Discard the supernatant. Resuspend the gold particles in 24 µl of 100% ethanol and apply 6 µl to each macrocarrier. Allow the ethanol to evaporate.
5.
Place the protonemal tissue so that it is about 150 mm below the stopper plate of the Bio-Rad PDS-1000/He biolistic particle delivery system. Make two discharges into each dish, moving the position of the dish between discharges. 
MATERIALS
Reagents
Isopropanol <!> cold? Liquid nitrogen <!> Nuclei isolation buffer containing β-mercaptoethanol (NIBM) <R> <!> Nuclei isolation buffer containing Triton X-100 (NIBT) <R> <! 2. Weigh 100 mg of tissue and freeze it in liquid nitrogen. Then, using a prechilled spatula, transfer the frozen tissue to a prechilled 2-ml microcentrifuge tube.
3.
Grind the frozen tissue in liquid nitrogen using a prechilled microcentrifuge tube pestle. Make sure the tissue remains frozen.
4.
Add 400 µl of prechilled? 1x Shorty buffer to the tube and mix well.
5. Centrifuge the sample in a microcentrifuge at maximum speed for 5 minutes .
6. Transfer 300 µl of the supernatant to a fresh 2-ml microcentrifuge tube containing 300 µl of cold?? isopropanol. Mix by inverting the tube.
7.
Centrifuge the sample at 16,000g for 10 minutes temp??.
8. Discard the supernatant and dry the pellet by inverting the tube on a paper towel. 
B. Isolation of High-molecular-weight DNA
1. Blot the tissue of moisture by sandwiching the tissue between sheets of filter paper and firmly compressing the tissue with the thumb.
2.
Weigh the blotted tissue and record the mass in grams.
3. Freeze the tissue in liquid nitrogen. Then, using a liquid-nitrogen-chilled mortar and pestle, grind the frozen tissue to a coarse powder. Transfer the ground tissue to a 1-liter Erlenmeyer flask.
4.
To the flask, add 13.3 ml of cold NIBM per gram of tissue.
5. Gently shake the flask by slowly rotating it for 15 minutes at 4°C.
6. Filter the ground tissue through four layers of cheesecloth plus one layer of Miracloth.
The filtrate will contain nuclei.
7. Squeeze the pellet to allow maximum recovery of nucleus-containing solution. 8. Filter the filtrate again through one layer of Miracloth.
9. To the filtrate, add 1 ml of NIBT for every 30 ml of filtrate. Gently shake the mixture by slowly rotating it for 15 minutes at 4°C.
10.
Transfer the mixture to 50-ml centrifuge tube and centrifuge at 2400g for 15 minutes at 4°C.
11. Discard the supernatant and gently resuspend the pellets in the residual buffer by tapping the tubes or by mixing with a small paintbrush.
12. Dilute the nuclei suspensions with NIBM and combine them into two 50-ml centrifuge tubes. Adjust the total volume in each tube to 50 ml with NIBM and centrifuge at 2400g for 15 minutes at 4°C.
13. Discard the supernatant and gently resuspend the pellets in the residual buffer by tapping the tubes or by mixing with a small paintbrush.
14. Dilute the nuclei suspensions with NIBM and combine them into one 50-ml centrifuge tube. Adjust the total volume to 50 ml with NIBM and centrifuge at 2400g for 15 minutes at 4°C.
15.
Discard the supernatant and resuspended the pellet in the residual buffer (1 ml). Use the resuspended pellet, which is enriched in nuclei, as the starting material for genomic DNA extraction with the Nucleon PhytoPure Genomic DNA Extraction Kit (GE Healthcare). 
